Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 181

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

An Interleukin-23-Interleukin-22 Axis Regulates Intestinal Microbial Homeostasis to Protect from Diet-Induced Atherosclerosis

Open access
Fatkhullina, Aliia R., Peshkova, Iuliia O., Dzutsev, Amiran, Aghayev, Turan, McCulloch, John A., Thovarai, Vishal, Badger, Jonathan H., Vats, Ravi, Sundd, Prithu, Tang, Hsin-Yao, Kossenkov, Andrew V., Hazen, Stanley L., Trinchieri, Giorgio, Grivennikov, Sergei I., Koltsova, Ekaterina K.·2018·Immunity

Abstract

&NA; Although commensal flora is involved in the regulation of immunity, the interplay between cytokine signaling and microbiota in atherosclerosis remains unknown. We found that interleukin (IL)‐23 and its downstream target IL‐22 restricted atherosclerosis by repressing pro‐atherogenic microbiota. Inactivation of IL‐23‐IL‐22 signaling led to deterioration of the intestinal barrier, dysbiosis, and expansion of pathogenic bacteria with distinct biosynthetic and metabolic properties, causing systemic increase in pro‐atherogenic metabolites such as lipopolysaccharide (LPS) and trimethylamine N‐oxide (TMAO). Augmented disease in the absence of the IL‐23‐IL‐22 pathway was mediated in part by pro‐atherogenic osteopontin, controlled by microbial metabolites. Microbiota transfer from IL‐23‐deficient mice accelerated atherosclerosis, whereas microbial depletion or IL‐22 supplementation reduced inflammation and ameliorated disease. Our work uncovers the IL‐23‐IL‐22 signaling as a regulator of atherosclerosis that restrains expansion of pro‐atherogenic microbiota and argues for informed use of cytokine blockers to avoid cardiovascular side effects driven by microbiota and inflammation. Graphical Abstract Figure. No caption available. HighlightsIL‐23 and IL‐22 cytokines restrict atherosclerosis developmentIL‐23 and IL‐22 control intestinal barrier and pro‐atherogenic bacteria expansionBacterial metabolites activate myeloid cells and drive atherosclerosis &NA; While anti‐cytokine therapies show promising results in autoimmune diseases, its effects on cardiovascular disease development are not well understood. Fatkhullina and colleagues show that inactivation of IL‐23‐IL‐22 signaling leads to deterioration of the intestinal barrier, expansion of pro‐atherogenic bacteria, and production of metabolites promoting macrophage activation and atherosclerosis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.immuni.2018.09.011

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 14 references

Cited by

See all 181

Metadata

Authors
Fatkhullina, A. R., Peshkova, I. O., Dzutsev, A., Aghayev, T., McCulloch, J. A., Thovarai, V., Badger, J. H., Vats, R., Sundd, P., Tang, H.-Y., Kossenkov, A. V., Hazen, S. L., Trinchieri, G., Grivennikov, S. I., & Koltsova, E. K.
Venue
Immunity
Publisher
Elsevier BV
Published
2018-11
Volume
49
Issue
5
Pages
943-957.e9
ISSN
1074-7613 (ISSN-L)
OpenAlex
W2898798903
Cited by
181
References
14
FWCI
7.38
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: An Interleukin-23-Interleukin-22 Axis Regulates Intestinal Microbial Homeostasis to Protect from Diet-Induced Atherosclerosis. https://app.cochat.ai/papers/10.1016/j.immuni.2018.09.011
The paper
Fatkhullina, A. R., Peshkova, I. O., Dzutsev, A., Aghayev, T., McCulloch, J. A., Thovarai, V., Badger, J. H., Vats, R., Sundd, P., Tang, H.-Y., Kossenkov, A. V., Hazen, S. L., Trinchieri, G., Grivennikov, S. I., & Koltsova, E. K. (2018). An Interleukin-23-Interleukin-22 Axis Regulates Intestinal Microbial Homeostasis to Protect from Diet-Induced Atherosclerosis. Immunity. https://doi.org/10.1016/j.immuni.2018.09.011

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.